On November 23, 2022 GNS, the leader in the application of Causal AI and simulation and "Digital Twins" to discover new drugs, reported two abstracts and two oral poster presentations highlighting insight from the Gemini Digital Twin models in Alzheimer’s Disease and Multiple Myeloma will be included at the Clinical Trials on Alzheimer’s Disease conference (CTAD) in San Francisco and the American Society of Hematology (ASH) (Free ASH Whitepaper) in New Orleans (Press release, GNS Healthcare, NOV 23, 2022, View Source;ash-2022-annual-conferences-301686187.html [SID1234624405]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Oral Poster Presentations:
Two oral poster presentations highlighting insight from the Gemini Digital Twin models in AD and MM will be included
CTAD – Abstract Title: Causal in silico Patient Models can inform Alzheimer’s Disease Patient Identification and Endpoint Selection for Early-Stage Clinical Trials
Authors: So-Youn Shin, Shokeen Deepanshi, Apoorva Bharthur, Todd Oakland, and Jeanne Latourelle
Location: Poster #158, Theme: Cognitive Assessment and Clinical Trials
Date: Friday, December 2nd, 2022, 8:00 AM-5:00 PM
ASH – Abstract Title: Causal AI in silico Patient Model Identifies Minichromosome Maintenance (MCM) Family Genes as Novel Predictors for Overall Survival in Multiple Myeloma
Authors: Daniel Vagie, Derek Walkama, Laurel Mayhew, Todd Oakland, and Bruce Church
Location: Session 803, Emerging Tools, Techniques and Artificial Intelligence in Hematology: Poster III
Date: Monday, December 12, 2022, 6:00 PM-8:00 PM
In accordance with CTAD and ASH (Free ASH Whitepaper) policies, abstracts and posters submitted are embargoed from the time of submission. Full text of both abstracts and posters will be made available on GNS website following their respective presentations at the conferences.